Understanding the role of Tet2 in blood cell formation and related disorders
Dissecting the canonical and non-canonical functions of Tet2 in hematopoietic stem cells and hematologic disorders
This study is looking at how changes in the Tet2 gene affect blood cell production and could help us understand blood disorders like myelodysplastic syndrome (MDS), which might lead to new treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11048543 on NIH RePORTER |
What this research studies
This research investigates how the Tet2 gene affects hematopoietic stem cells, which are responsible for producing blood cells. By using specially designed mice that lack certain functions of Tet2, researchers aim to differentiate between its roles in regulating blood cell production and its involvement in blood disorders like myelodysplastic syndrome (MDS). The study seeks to uncover the mechanisms by which Tet2 mutations contribute to these conditions, potentially leading to new therapeutic strategies. Patients may benefit from insights gained about MDS and related blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those aged 65 and above, who may be affected by myelodysplastic syndrome or similar blood disorders.
Not a fit: Patients under the age of 65 or those without hematologic disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with myelodysplastic syndrome and other hematologic disorders.
How similar studies have performed: Previous research has shown that understanding the genetic factors involved in blood disorders can lead to significant advancements in treatment, suggesting that this approach has the potential for success.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Ito, Keisuke — Albert Einstein College of Medicine
- Study coordinator: Ito, Keisuke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.